Blue Light Versus Green Light Autofluorescence
Blue Light Versus Green Light Autofluorescence Blue Light Versus Green Light Autofluorescence
IOVS Papers in Press. Published on November 22, 2011 as Manuscript iovs.11-8346 Blue Light versus Green Light Autofluorescence: Lesion Size of Areas with Geographic Atrophy Ute EK Wolf-Schnurrbusch 1,2 , Valéry V Wittwer 1,2 , Ramzi Ghanem 1,3 , Martin Niederhaeuser 2 , Volker Enzmann 1 , Carsten Framme 1 , Sebastian Wolf 1,2 1 Universitätsklinik für Augenheilkunde, Inselspital, University of Bern, Switzerland 2 Bern Photographic Reading Center, Inselspital, University of Bern, Switzerland 3 Helios Klinikum, Aue, Germany ClinicalTrials.gov Identifier: NCT00494325 Financial interests: none Word count: 3029 Corresponding author: Ute Wolf-Schnurrbusch University Eye Hospital Inselspital CH-3010 Bern, Switzerland Phone: +41 31 632 85 75 Fax: +41 31 632 1810 E-mail: ute.wolf@insel.ch 1 Copyright 2011 by The Association for Research in Vision and Ophthalmology, Inc.
- Page 2 and 3: Abstract Introduction Blue light fu
- Page 4 and 5: development of atrophic patches in
- Page 6 and 7: 2. Intermediate quality: All areas
- Page 8 and 9: In both, blue (�1=488 nm) and gre
- Page 10 and 11: areas due to inter-subject variabil
- Page 12 and 13: In current clinical studies, only b
- Page 14 and 15: Figure 2: Example for a FAF image w
- Page 16 and 17: Figure 4: Example of a FAF image wi
- Page 18 and 19: Figure 6: Bland-Altman plots for th
- Page 20 and 21: References 1. Wüstemeyer H, Jahn C
IOVS Papers in Press. Published on November 22, 2011 as Manuscript iovs.11-8346<br />
<strong>Blue</strong> <strong>Light</strong> versus <strong>Green</strong> <strong>Light</strong> <strong>Autofluorescence</strong>:<br />
Lesion Size of Areas with Geographic Atrophy<br />
Ute EK Wolf-Schnurrbusch 1,2 , Valéry V Wittwer 1,2 , Ramzi Ghanem 1,3 , Martin<br />
Niederhaeuser 2 , Volker Enzmann 1 , Carsten Framme 1 , Sebastian Wolf 1,2<br />
1 Universitätsklinik für Augenheilkunde, Inselspital, University of Bern, Switzerland<br />
2 Bern Photographic Reading Center, Inselspital, University of Bern, Switzerland<br />
3 Helios Klinikum, Aue, Germany<br />
ClinicalTrials.gov Identifier: NCT00494325<br />
Financial interests: none<br />
Word count: 3029<br />
Corresponding author: Ute Wolf-Schnurrbusch<br />
University Eye Hospital<br />
Inselspital<br />
CH-3010 Bern, Switzerland<br />
Phone: +41 31 632 85 75<br />
Fax: +41 31 632 1810<br />
E-mail: ute.wolf@insel.ch<br />
1<br />
Copyright 2011 by The Association for Research in Vision and Ophthalmology, Inc.
Abstract<br />
Introduction<br />
<strong>Blue</strong> light fundus autofluorescence (FAF) imaging is currently widely used for<br />
assessing dry age-related macular degeneration (ARMD). However, at this<br />
wavelength the fovea appears as circular zone of marked hypofluorescence due to<br />
the absorption of macular pigment (MP). This dark spot could be misinterpreted as<br />
atrophic area and could lead to difficulties in identifying small central changes. The<br />
aim of the study was to analyze differences in image quality, FAF patterns, and lesion<br />
size of using conventional blue (�1=488 nm) and green light FAF (�2=514 nm).<br />
Material and Methods<br />
Patients older than 50 years with central areas of geographic atrophy (GA) secondary<br />
to ARMD were enrolled. Images were recorded with a modified confocal scanning<br />
laser ophthalmoscopy (cSLO). Image quality and patterns were analyzed. The<br />
quantification of the GA was performed with a customized analysis imaging software.<br />
Results<br />
In total 95 eyes were included. Borders of the central atrophic patches and boundaries of<br />
preserved foveal island were better identified in 514 nm images. In both excitation<br />
wavelengths the signal-to-noise ratio was sufficient for the identification of FAF pattern.<br />
We found significant differences in the size of the GA areas detected in the 488 nm and<br />
514 nm wavelength images (4.29 ± 3.76 mm 2 vs. 3.80 ± 3.68 mm 2 ; p
Using only blue light FAF could lead to an over-interpretation of the size of atrophic<br />
patches and the center involvement because it suggests the presence of atrophy in the<br />
fovea.<br />
Introduction<br />
Age-related macular degeneration (ARMD) is related to aging changes in the retinal<br />
pigment epithelium (RPE), Bruch’s membrane and choroid 2-4 . Aging of the RPE is<br />
characterized by massive accumulation of lipofuscin (LF) which contains several<br />
fluorophors. LF has been shown to contain toxic compounds including the dominant<br />
fluophore apyridinium-bis-retinoid (A2-E) which is derived from two molecules of<br />
vitamin A aldehyd and one molecule of ethanolamine 5 . A2E has been shown to<br />
inhibit lysosomal digestion of proteins and to act as a photosensitizer in blue light<br />
generating free radicals within the RPE cell. Based on conventional fundus<br />
photographs, areas of GA have been defined as a sharply demarcated area of<br />
apparent absence of RPE, larger than 175 μm, with visible choroidal vessels and no<br />
neovascular ARMD 25, 28, 29 . This definition is based on histopathological studies that<br />
have characterized clinically visible areas of GA as areas with RPE and outer<br />
neurosensory layer cell death with occasionally visible choriocapillaris 25, 28 . With the<br />
advent of confocal scanning laser ophthalmoscopy (cSLO), fundus autofluorescence<br />
(FAF) can be visualized in vivo 6-8 .<br />
FAF is a relatively novel imaging method that allows topographic LF mapping in vivo<br />
6-11 . In most studies, blue-light FAF images using an excitation wavelength of 488 nm<br />
were analyzed. It is possible to use the non-invasive FAF imaging to monitor disease-<br />
associated changes in-vivo. This is important for the characterization of the atrophic<br />
late-stage manifestation of dry ARMD. This disease is characterized by the<br />
3
development of atrophic patches in the RPE monolayer. Due to the absence of RPE<br />
lipofuscin, areas of geographic atrophy (GA) exhibit a notable reduced FAF signal.<br />
These atrophic areas can be detected clearly and can be quantified precisely in FAF<br />
images.<br />
Imaging of FAF with a cSLO is usually performed with an excitation wavelength of<br />
488 nm. At this wavelength macular pigment (MP) significantly absorbs. This results<br />
in circular zone of marked hypofluorescence (visible as a darker spot) overlying the<br />
fovea and the surrounding area of about 0.5 mm 9, 12, 13 . This reduction of FAF<br />
intensity in the fovea could lead to difficulties in identifying small central changes and<br />
may influence the identification of foveal involvement in central atrophic changes.<br />
The aim of this prospective cross-sectional study was to analyze differences in image<br />
quality, FAF pattern and lesion size measurements of areas with GA at the central<br />
posterior pole using conventional blue light autofluorescence (�1=488 nm) and green<br />
light autofluorescence (�2=514 nm).<br />
Material and Methods<br />
Patients from the outpatient department, Department of Ophthalmology, Inselspital,<br />
University Bern, Switzerland were screened between 5/2007 and 9/2011 for study<br />
participation. Patients older than 50 years with clear optical media and areas of<br />
unifocal or multifocal GA areas secondary to dry ARMD were enrolled. If both eyes<br />
qualified equally for the study, one eye was randomly chosen. Prior to any study<br />
procedures, informed written consent was obtained from every patient with<br />
explanation of the nature and possible risks of the study. The research followed the<br />
4
tenets of the Declaration of Helsinki and was approved by the Institutional Review<br />
Board.<br />
Exclusion criteria were any confluent papillary atrophy in contact with central atrophy,<br />
signs of wet ARMD, any history of retinal surgery (including laser treatment) or<br />
diabetic retinopathy, vascular occlusion, and hereditary retinal dystrophy. We<br />
performed a comprehensive ocular examination with best-corrected visual acuity<br />
(BCVA) using Early Treatment Diabetic Retinopathy Study (ETDRS) charts, dilated<br />
binocular ophthalmoscopy and color fundus photography (FF 450 plus, Carl Zeiss<br />
Meditec, Jena, Germany). All patients underwent fluorescein angiography using the<br />
Heidelberg Retina Angiograph (HRA2, Heidelberg Engineering, Heidelberg,<br />
Germany) to confirm the diagnosis of dry ARMD and to exclude neovascularizations.<br />
FAF images were recorded according to a standardized operation protocol 12, 13 with<br />
a modified cSLO (HRAmp, Heidelberg Engineering, Heidelberg, Germany). This<br />
instrument has been optimized for FAF imaging at excitation wavelengths of<br />
�1=488 nm and �2=514 nm 1 . The patients were positioned in front of the HRAmp and<br />
instructed to look straight and steady. After aligning and focusing using 20°<br />
reflectance images at 488 nm wavelengths the retina was bleached for at least 30<br />
seconds. Then 20° FAF images were acquired at 488 nm and 514 nm wavelengths.<br />
A total of 9 FAF images were recorded for each wavelength. The images obtained for<br />
each wavelength were averaged using the system software to reduce speckle noise.<br />
This improves the signal-to-noise ratio by a factor of 3. The averaged images were<br />
then normalized and graded as follows:<br />
1. Good quality: All areas of GA are clear visible and all boundaries of all GA<br />
areas are delineable. The signal-to-noise ratio is sufficient for the identification<br />
5
2. Intermediate quality: All areas of GA are visible and all boundaries of all GA<br />
areas are discernible. However the signal-to-noise ratio was too low for<br />
sufficient identification of FAF pattern in the junctional zone but still sufficient<br />
for the pattern grading of the posterior pole.<br />
3. Inferior quality. Neither all borders of GA nor FAF abnormalities are entirely<br />
readable.<br />
In all images with good or intermediate quality the FAF patterns and the total size of<br />
GA were analyzed. We quantified the total GA size using the Region Finder software<br />
Version 1.0.16 (Heidelberg Engineering, Heidelberg, Germany). The software<br />
includes algorithms for semi automated segmentation of atrophic areas and for<br />
automated identification of interfering vascular structures 14 . Starting from a user-<br />
defined seed point placed in a dark area of the image a so called “Region grow<br />
algorithm” identifies the border of this dark area and calculates a mean grey value of<br />
the pixels. The FAF intensity of every picture element (pixel) is given in a certain grey value.<br />
The dramatic decrease of the FAF signal in GA areas compared to non-atrophic retinal areas<br />
is used by the Region Finder software for the segmentation of areas with GA. Following the<br />
definition of the center of a region by the operator (reader), the so-called region growing<br />
algorithm tends to grow towards the borders of the region taking into account all pixels with a<br />
signal intensity below a certain threshold. This threshold is defined by a parameter referred<br />
to as “growth power”. The higher the growth power the larger the enclosed area. The proper<br />
adjustment of this parameter allows for the precise measurement of the area with GA. For<br />
scaling, the individual scaling factor that is registered by the HEYEX during acquisition is<br />
used. Given the digital image resolution of 768 x 768 pixels of a 30° x 30° frame, one pixel<br />
roughly corresponds to 11 microns.<br />
6
Two independent and trained readers (MN, VW) assessed the image quality and<br />
quantified the total GA size in FAF images at excitation wavelengths of �1=488 nm<br />
and �2=514 nm. The readers analyzed the images in separate sessions at least one<br />
day apart. In each session the images were presented in a randomized fashion to<br />
minimize any memory effect. For statistical analysis of lesion size the measurements<br />
between the two independent graders were averaged. Inter FAF mode variability was<br />
analyzed using Bland-Altman plots. The inter-observer agreement for both FAF<br />
modes (e.g. �1=488 nm and �2=514 nm) was analyzed with the Bland-Altman plots<br />
and the Lin’s concordance correlation coefficient. We used GraphPad Prism version<br />
5.00 for Windows (GraphPad Software, San Diego California USA,<br />
www.graphpad.com) for all statistical analyses. P values ≤ 0.05 were accepted as<br />
statistically significant given the exploratory nature of these analyses. Demographic<br />
characteristics for the patients were summarized using descriptive statistics.<br />
Descriptive statistics are expressed in terms of means ± standard deviation (M±SD)<br />
or proportions.<br />
Results<br />
In total 95 eyes with GA areas secondary to dry ARMD involving the central posterior<br />
pole of the eye were included into this unmasked, prospective cross-sectional study.<br />
Baseline demographics of all the 95 patients are described in Table 1.<br />
FAF imaging with the modified cSLO was possible in all 95 eyes using the 488 nm<br />
and the 514 nm excitation wavelength. In all eyes, we found a reduced FAF signal in<br />
the GA site when using both wavelengths.<br />
Assessment of the image quality<br />
7
In both, blue (�1=488 nm) and green (�2=514 nm) excitation light FAF images, the<br />
signal-to-noise ratio was sufficient for the quality assessment. We did not observe<br />
differences in the quality assessment between both excitation wavelengths and the<br />
two independent readers.In general the 488 nm images had a slightly better contrast<br />
outside the macula region. Borders of the GA patches involving the macula or<br />
boundaries of any existing preserved foveal island were better to identify in 514 nm<br />
compared to 488 nm FAF images.<br />
We found in 58/95 (61%) eyes a “good” image quality and in 26/95 (27%) a<br />
“intermediate” image quality. Representative examples for the image quality<br />
assessment are shown below in Figure 1 and 2 (good image quality) and Figure 3<br />
(intermediate image quality). An “inferior” quality was found in 11/95 (12%) eyes.<br />
Reasons for reduced image quality, included slow eye movements during image<br />
acquisition which is not corrected by averaging algorithm of the software (9/11 eyes)<br />
and vitreous floaters (2/11 eyes).<br />
Neither the lens status (phacic vs. pseudophakic, p> 0.05 Chi-square test) nor the<br />
type of the intraocular lens (IOL) (clears vs. blue blocking IOL, p> 0.05 Chi-square<br />
test) had any influence on the FAF image quality. The refraction or the spherical<br />
equivalent also did not influence the image quality. For the analyses of the lesion size<br />
and the FAF patterns we excluded all 11/95 (12%) eyes with an inferior quality.<br />
Assessment of the FAF patterns<br />
With both excitation wavelengths (488 nm and 514nm) the signal-to-noise ratio was<br />
sufficient for the identification of FAF pattern. The distribution of FAF patterns was<br />
similar for 488 nm and 514 nm FAF images. A total of 13/84 (15%) eyes showed the<br />
GA without visible abnormal FAF outside the area of atrophy. The rest of the 71/84<br />
(85%) eyes, presented different forms of abnormal FAF patterns surrounding the<br />
8
area of GA. A FAF pattern with a small continuous band at the margin with variable<br />
peripheral extension was noted in the majority of these eyes (48/71, 68%). A FAF<br />
pattern with a diffusely increased autofluorescence at the entire posterior pole was<br />
seen in 12/71 (17%) eyes (Figure 1 and 3), and a FAF with small focal spots of<br />
increased autofluorescence in the junctional zone was observed in 11/71 (15%) eyes<br />
(Figure 2).<br />
Assessment of the total GA size<br />
In all the FAF image sets, the total size of GA was delineated and quantified.<br />
However, in 15 of the 84 (18%) eyes the total size of the atrophic patches was too<br />
large to visualize all peripheral borders in the FAF images (see Figure 4). Therefore,<br />
the size of the GA was only assessable in image sets from 69 eyes. We found<br />
significant differences in the size of the GA areas detected in the 488 nm and 514 nm<br />
wavelength images (4.29 ± 3.76 mm 2 vs. 3.80 ± 3.68 mm 2 ; p 0.05) between both readers for a given<br />
wavelength. The correlation between both observers was good with a Lin<br />
concordance correlation coefficient of 0.965 for 488 nm images and of 0.930 for<br />
514 nm images. Bland-Altman plots for the inter-reader variability are presented in<br />
Figure 5.<br />
Discussion<br />
The majority of epidemiological and natural history studies that have addressed the<br />
enlargement of GA areas with time have used color fundus photographs 23-25 or fundus-<br />
camera based FAF images. While this technique can be used to detect the presence of<br />
GA, graders at reading centers have reported difficulty reproducibly measuring atrophic<br />
9
areas due to inter-subject variability of fundus pigmentation, media opacities and the<br />
presence of drusen and small satellites of atrophy 26-28 .<br />
The aim of this study was to analyze differences in image quality, FAF patterns and<br />
total GA size measurements using conventional blue light autofluorescence (488 nm)<br />
and green light autofluorescence (514 nm). Imaging of FAF distribution using<br />
conventional blue light autofluorescence is a relatively well established method to<br />
assess the LF distribution in a clinical setting 6-11 . For the image acquisition we used<br />
a modified cSLO optimized for macular pigment measurements 1, 15-17, 20 . This<br />
instrument allows FAF imaging with two excitation wavelengths (�1=488 nm and<br />
�2=514 nm) 15-17 .<br />
Good or intermediate image quality is needed no matter what excitation wavelength<br />
is used. In FAF images with “inferior” quality, neither the FAF patterns nor all borders<br />
of GA are readable. A high-contrast difference between atrophic and non-atrophic<br />
areas is necessary for an exact measurement of the GA size. This high-contrast<br />
difference between the atrophic and non-atrophic area is also needed for a clear<br />
delineation of GA boundaries.<br />
In most eyes with clear optical media (87%), good or intermediate FAF imaging<br />
quality was observed with both excitation wavelengths. Overall, image quality and<br />
distribution of FAF patterns did not differ between of the two wavelengths.<br />
Both wavelengths could be used for a fast and non-invasive detection of disease<br />
associated changes in patients with GA. Areas with GA show decreased FAF signal<br />
due to the lack of RPE which contains LF as a dominant fluophore. The areas<br />
adjacent to the GA show a broad spectrum of autofluorescence pattern. These<br />
patterns were well established using blue light autofluorescence images and seem to<br />
offer a certain predictive value for disease progression 18, 19 .<br />
10
In this study areas of GA showed a marked reduced autofluorescence signal with<br />
both wavelengths. Adjacent to the GA areas we were able to detect the previously<br />
described FAF patterns with both wavelengths. The relative distribution of FAF<br />
patterns in the present study was similar to other patients cohorts previously tested<br />
20 .<br />
Quantification of the atrophic patches using customized analysis imaging software<br />
has previously been described 14 . FAF with both excitation wavelengths (488 nm and<br />
514 nm) allowed the delineation of the borders of the GA. Significant differences<br />
were found when comparing the size of the atrophic patches between both used<br />
excitation wavelengths. We observed significant differences in the size of the GA<br />
areas detected in the 488 nm and 514 nm wavelength images (4.29 ± 3.76 mm 2 vs.<br />
3.80 ± 3.68 mm 2 ; p0.05).<br />
Central pathologies were clearer to distinguish and easier visible if the longer<br />
excitation wavelength (514 nm) was used. Preserved foveal islands were clearer to<br />
distinguish in FAF images with 514 nm excitation wavelength. The dominant cause<br />
for misinterpretation at 488 nm wavelength was the dark spot overlaying the fovea<br />
due to MP absorption. This could lead to a false- or an over-interpretation of the GA<br />
size, and the center involvement because it suggests the presence of atrophy in the<br />
fovea. This could explain the differences in the size measurements between both<br />
wavelengths. The differences in the size measurements between both FAF modes<br />
are not important, if only the progression rate or the enlargement of GA areas are studied in<br />
a longitudinal fashion. But in our opinion it is important to give the correct baseline<br />
characteristic for the center involvement and for a correlation with functional values like<br />
BCVA in epidemiological or natural history studies 23-25 .<br />
11
In current clinical studies, only blue-light FAF is used to determine the size of atrophic<br />
lesions. However, an accurate measurement with green light FAF is important in<br />
future clinical trials for the evaluation of the central GA progression. As a result, the<br />
use of green light FAF images could give us a better opportunity in estimating an<br />
approximate time of visual loss. Depending which wavelength is used a detailed<br />
description is needed for a precise interpretation of focally increased or decreased<br />
FAF signals. Therefore future studies are necessary to evaluate the clinical value of<br />
this new imaging method in order to understand green light autofluorescence better.<br />
Although lipofuscin is the dominant fluorophor in the ocular fundus, there are many<br />
other fluorophors present anterior and posterior to the RPE cell monolayer, including<br />
elastin and collagen 21 . Fluorophors like melanin could contribute to the detected FAF<br />
above 695 nm if near infra red (IR) wavelengths were used 22 . This could complicate<br />
the interpretation of FAF images obtained with wavelengths longer than 600 nm<br />
instead of the conventional blue light.<br />
To conclude, the green light FAF images obtained with 514 nm excitation wavelength<br />
are superior for an accurate determination of small central pathologic changes and of<br />
the central atrophic lesion boundaries.<br />
Acknowledgements<br />
We thank Ms. Anita Zenger for her help in the image acquisition and Bettina<br />
Rotzetter for the reading of the manuscript.<br />
12
Figures<br />
Figure 1:<br />
Example of a FAF image with good quality (right eye, O-Y, f, 78 years old, BCVA 63<br />
letters, correction +1.25 dpt. and +0.5 dpt. / 96°). All areas of GA are clear visible and<br />
all boundaries are delineable. The signal-to-noise ratio is sufficient for the<br />
identification of the FAF patterns in the junctional zone around the GA and for the<br />
detailed grading of the posterior pole.<br />
Left: FAF image with an excitation wavelength of 488 nm (total GA size 1.621 mm 2 ).<br />
Middle: FAF image with an excitation wavelength of 514 nm (total GA size 1.554<br />
mm 2 ).<br />
Right: color fundus photography.<br />
13
Figure 2:<br />
Example for a FAF image with good quality (right eye, WL, f, 92 years old, BCVA 38<br />
letters, correction -1.00 dpt. and +0.50 dpt. / 112°). Central boundaries of the atrophic<br />
areas were more clearly visible if the “dark spot” produced by the MP was absent.<br />
This resulted in a significantly smaller size of the atrophic patches if FAF with an<br />
excitation wavelength was used.<br />
Left: FAF image with an excitation wavelength of 488 nm (total GA size 4.789 mm 2 ).<br />
Middle: FAF image with an excitation wavelength of 514 nm (total GA size 3.917<br />
mm 2 ).<br />
Right: color fundus photography.<br />
14
Figure 3:<br />
Example for a FAF image with intermediate quality (right, AA, f, 90 years old, BCVA<br />
44 letters, correction -1.00 dpt. and +0.75 dpt. / 172°). All areas of GA are visible and<br />
all boundaries of all GA areas are discernible. The signal-to-noise ratio was too low<br />
for sufficient identification of all FAF patterns in the junctional zone.<br />
Left: FAF image with an excitation wavelength of 488 nm (total GA size 2.643 mm 2 ).<br />
Middle: FAF image with a excitation wavelength of 514 nm (total GA size 2.169<br />
mm 2 ).<br />
Right: color fundus photography.<br />
The foveal island is clearer visible especially in the 514 nm FAF image (see middle<br />
figure) because the “dark shadow” produced by the MP is not covering the central<br />
region. If only FAF images with an excitation wavelength of 488 nm (left) is used this<br />
could lead to a false interpretation of the involved central region.<br />
15
Figure 4:<br />
Example of a FAF image with intermediate quality (right eye, PB, f, 78 years old,<br />
BCVA 27 letters, correction -0.5 dpt.).<br />
It was not possible to visualize all peripheral borders in the FAF images because the<br />
atrophic patches were too large. Therefore we excluded this eye because we were<br />
not able to calculate the exact size.<br />
The sizes of the preserved foveal islands are obviously different when comparing the<br />
two used wavelengths. In the 514 nm image an intact connection is precisely visible<br />
between the two preserved RPE islands (see middle figure).<br />
Left: FAF image with an excitation wavelength of 488 nm.<br />
Middle: FAF image with an excitation wavelength of 514 nm.<br />
Right: color fundus photography.<br />
16
Figure 5:<br />
Bland-Altman plot for the differences between the 488 nm and 514 nm FAF modes<br />
17
Figure 6:<br />
Bland-Altman plots for the inter-reader variability for each FAF mode (488 nm, 514<br />
nm)<br />
18
Tables<br />
Table 1:<br />
Demographic data of all patients (n=95)<br />
Mean Age � SD<br />
(range)<br />
78.8�7.4 years<br />
(range 62.9 to 90.9 years)<br />
Gender male: 34 (36%), female: 61 (64%)<br />
Mean letter score � SD<br />
(range); LogMar<br />
Spherical equivalent � SD<br />
(range)<br />
55 ± 20 letters<br />
(0 to - 81 letters); -0.6<br />
+0.5 ± 0.27 dpt.<br />
(+ 5.0 to – 12.0 dpt.)<br />
Lens status phacic: 47 (49%) eyes,<br />
pseudophacic: 48 (51%) eyes<br />
Typ of IOL clear IOL: 29 (60%) eyes<br />
blue-blocking IOL: 19 (40%) eyes<br />
SD: standard deviation, IOL: intra ocular lens, dpt.: diopters<br />
19
References<br />
1. Wüstemeyer H, Jahn C, Nestler A, Barth T, Wolf S. A new instrument for the<br />
quantification of macular pigment density: first results in patients with AMD and<br />
healthy subjects. Graefe's Arch Clin Exp Ophthalmol 2002;240:666-671.<br />
2. Bird AC. Pathogenesis of retinal pigment epithelial detachment in the elderly;<br />
the relevance of Bruch's membrane change. Eye 1991;5:1-12.<br />
3. <strong>Green</strong> WR, Enger C. Age-related macular degeneration histopathologic studies.<br />
Ophth 1993;100:1519-1535.<br />
4. Pauleikhoff D, Harper A, Marshall J, Bird A. Aging changes in Bruch´s<br />
membrane. A histochemical and morphologic study. Ophth 1990;97:171-178.<br />
5. Reinboth JJ, Gautschi K, Munz K, Eldred GE, Reme CE. Lipofuscin in the<br />
retina: quantitative assay for an unprecedented autofluorescent compound<br />
(pyridinium bis-retinoid, A2-E) of ocular age pigment. Exp Eye Res<br />
1997;65:639-643.<br />
6. Bird AC, Bressler NM, Bressler SB, et al. An international classification and<br />
grading system for age-related maculopathy and age-related macular<br />
degeneration. Surv OPhthalmol 1995;39:367-374.<br />
7. Delori FC, Fleckner MR, Goger DG, Weiter JJ, Dorey CK. <strong>Autofluorescence</strong><br />
distribution associated with drusen in age-related macular degeneration. Invest<br />
Ophthalmol Vis Sci 2000;41:496-504.<br />
8. Lois N, Halfyard AS, Bunce C, Bird AC, Fitzke FW. Reproducibility of fundus<br />
autofluorescence measurements obtained using a confocal scanning laser<br />
ophthalmoscope. Br J Ophthalmol 1999;83:276-279.<br />
9. Solbach U, Keilhauer C, Knabben H, Wolf S. Imaging of retinal<br />
autofluorescence in patients with age-related macular degeneration. Retina<br />
1997;17:385-389.<br />
10. Okubo A, Rosa RH, Jr., Bunce CV, et al. The relationships of age changes in<br />
retinal pigment epithelium and Bruch's membrane. Invest Ophthalmol Vis Sci<br />
1999;40:443-449.<br />
11. von Rückmann A, Fitzke F, Bird A. Fundus autofluorescence in age-related<br />
macular disease imaged with a scanning laser ophthalmoscope. Invest<br />
Ophthalmol Vis Sci 1997;38:478-486.<br />
12. Hammond BR, Jr., Wooten BR, Snodderly DM. Density of the human crystalline<br />
lens is related to the macular pigment carotenoids, lutein and zeaxanthin.<br />
Optom Vis Sci 1997;74:499-504.<br />
13. Snodderly DM, Handelman GJ, Adler AJ. Distribution of individual macular<br />
pigment carotenoids in central retina of macaque and squirrel monkeys. Invest<br />
Ophthalmol Vis Sci 1991;32:268-279.<br />
14. Deckert A, Schmitz-Valckenberg S, Jorzik J, Bindewald A, Holz FG, Mansmann<br />
U. Automated analysis of digital fundus autofluorescence images of geographic<br />
atrophy in advanced age-related macular degeneration using confocal scanning<br />
laser ophthalmoscopy (cSLO). BMC Ophthalmol 2005;5:8.<br />
15. Jahn C, Wüstemeyer H, Brinkmann C, et al. Macular pigment densitiy subject to<br />
different stages of age-realted maculopathy. 2004;ARVO Abstract.<br />
20
16. Wüstemeyer H, Moessner A, Jahn C, Wiedemann P, Wolf S. Macular pigment<br />
density in healthy subjects quantified with a modified confocal laser scanning<br />
ophthalmoscope. Graefes Arch Clin Exp Ophthalmol 2003.<br />
17. Wolf-Schnurrbusch UE, Roosli N, Weyermann E, Heldner MR, Hohne K, Wolf<br />
S. Ethnic differences in macular pigment density and distribution. Invest<br />
Ophthalmol Vis Sci 2007;48:3783-3787.<br />
18. Bindewald A, Dolar-Szczasny J, Sieber H, et al. Fundus autofluorescence<br />
patterns in the junctional zone als prognostic determinats for spreas of<br />
geographic atrophy in age-related macular degeneration (AMD). 2004;ARVO<br />
Abstract.<br />
19. Holz FG, Bindewald-Wittich A, Fleckenstein M, Dreyhaupt J, Scholl HP,<br />
Schmitz-Valckenberg S. Progression of geographic atrophy and impact of<br />
fundus autofluorescence patterns in age-related macular degeneration. Am J<br />
Ophthalmol 2007;143:463-472.<br />
20. Wolf-Schnurrbusch UE, Enzmann V, Brinkmann CK, Wolf S. Morphologic<br />
Changes in Patients with Geographic Atrophy Assessed with a Novel Spectral<br />
OCT-SLO Combination. Invest Ophthalmol Vis Sci 2008;49:3095-3099.<br />
21. Schweitzer D, Schenke S, Hammer M, et al. Towards metabolic mapping of the<br />
human retina. Microsc Res Tech 2007;70:410-419.<br />
22. Keilhauer CN, Delori FC. Near-infrared autofluorescence imaging of the fundus:<br />
visualization of ocular melanin. Invest Ophthalmol Vis Sci 2006;47:3556-3564.<br />
23. Sunness JS. The natural history of geographic atrophy, the advanced atrophic form of<br />
agerelatedmacular degeneration. Mol Vis 1999;5:25.<br />
24. Schatz H, McDonald HR. Atrophic macular degeneration. Rate of spread of geographic<br />
atrophy and visual loss. Ophthalmology 1989;96:1541-1551.<br />
25. Change in Area of Geographic Atrophy in the Age-Related Eye Disease Study: AREDS<br />
Report Number 26. Arch Ophthalmol 2009;127:1168-1174.<br />
26. Scholl HP, Dandekar SS, Peto T, Bunce C, Xing W, Jenkins S, Bird AC. What is<br />
lost by digitizing stereoscopic fundus color slides for macular grading in agerelated<br />
maculopathy and degeneration? Ophthalmology 2004;111:125-132.<br />
27. Sunness JS, Bressler NM, Tian Y, Alexander J, Applegate CA. Measuring<br />
geographic atrophy in advanced age-related macular degeneration. Invest<br />
Ophthalmol Vis Sci 1999;40:1761-1769.<br />
28. Pirbhai A, Sheidow T, Hooper P. Prospective evaluation of digital non-stereo color fundus<br />
photography as a screening tool in age-related macular degeneration. Am J<br />
Ophthalmol 2005;139:455-461.<br />
28. Sarks JP, Sarks SH, Killingsworth MC. Evolution of geographic atrophy of the retinal<br />
pigment epithelium. Eye 1988;2 552-577.<br />
29. Sarks SH. Ageing and degeneration in the macular region: a clinico-pathological study.<br />
Br J Ophthalmol 1976;60:324-341.<br />
21